See also this year's filing and all EDGAR filings for this company.
PDF Report 0001427925_2023_ACELRX_PHARMACEUTICALS_INC.pdf
Logs
Graph
Absolute values for 0001427925, ACELRX PHARMACEUTICALS INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 24,566,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 8,819,000 |
| 2 | PropertyPlantAndEquipmentNet | 10,261,000 |
| 3 | remainder_Assets | 3,841,000 |
| 4 | LiabilitiesCurrent | 13,770,000 |
| 5 | LiabilitiesNoncurrent | 4,805,000 |
| 6 | remainder_Liabilities | 7,098,000 |
| 7 | CostOfGoodsAndServicesSold | 2,591,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 25,672,000 |
| 9 | ResearchAndDevelopmentExpense | 5,193,000 |
| 10 | remainder_Expenses | 4,961,000 |
| 11 | remainder_Revenues | 1,771,000 |
| 12 | remainder_NetIncome | 84,401,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 47,487,000 |
| 1 | Liabilities | 25,673,000 |
| 2 | Expenses | 38,417,000 |
| 3 | Revenues | 1,771,000 |
| 4 | StockholdersEquity | 21,814,000 |
| 5 | NetIncome | 47,755,000 |
| 6 | ComprehensiveNetIncome | 47,755,000 |
| 7 | BaseVar | 98,874,500 |
| 8 | EconomicCapitalRatio | 2.33 |
Edgar->Model Mapping
Feature Distribution
Change over Time
